Stockscreener 앱 받기
11.83
1.66%
-0.20
시간 외 거래:
11.83
전일 마감가:
$12.03
열려 있는:
$11.98
하루 거래량:
450.65K
Relative Volume:
0.97
시가총액:
$480.70M
수익:
$324.01M
순이익/손실:
$-192.37M
주가수익비율:
-2.4749
EPS:
-4.78
순현금흐름:
$-23.46M
1주 성능:
-3.74%
1개월 성능:
+1.63%
6개월 성능:
+27.34%
1년 성능:
+77.10%
1일 변동 폭
$11.67
$12.04
1주일 범위
$11.67
$12.45
52주 변동 폭
$6.61
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
명칭
Angiodynamic Inc
전화
(518) 798-1215
주소
14 PLAZA DRIVE, LATHAM
ANGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
11.83 | 495.63M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 개시 | Lake Street | Buy |
| 2024-04-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 개시 | H.C. Wainwright | Buy |
| 2023-04-17 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 개시 | Oppenheimer | Perform |
| 2020-11-25 | 업그레이드 | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2017-04-07 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-03-30 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 개시 | Barclays | Equal Weight |
| 2016-11-04 | 개시 | Cantor Fitzgerald | Buy |
| 2016-04-08 | 재개 | Piper Jaffray | Neutral |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 재확인 | Canaccord Genuity | Hold |
| 2012-06-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | 업그레이드 | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2010-09-08 | 재확인 | Wedbush | Neutral |
모두보기
Angiodynamic Inc 주식(ANGO)의 최신 뉴스
AngioDynamics, Inc. $ANGO Stock Position Raised by Pier Capital LLC - MarketBeat
Why analysts upgrade AngioDynamics Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Why analysts raise outlook for AngioDynamics Inc. (UG2) stockTrade Performance Summary & AI Driven Price Forecasts - fcp.pa.gov.br
AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan
ANGO registers 4.7M plan shares and covers 2.53M insider resales - Stock Titan
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - Trung tâm Dự báo KTTV quốc gia
Insider Spends US$112k Buying More Shares In AngioDynamics - Yahoo Finance
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - Trung tâm Dự báo KTTV quốc gia
AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Time magazine names Latham-based AngioDynamics' cancer-fighting NanoKnife a top invention - Times Union
Published on: 2025-10-15 06:33:40 - newser.com
Analyzing AngioDynamics Inc. with multi timeframe chartsJuly 2025 Decliners & Smart Investment Allocation Insights - newser.com
Can technical indicators confirm AngioDynamics Inc.’s reversal - newser.com
Custom watchlist performance reports with AngioDynamics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List - Stock Titan
AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st
AngioDynamics Inc (ANGO) CEO James Clemmer Purchases 10,000 Shar - GuruFocus
AngioDynamics Inc UG2 Stock Analysis and ForecastBreakout Stock Watch & Capital Efficiency Improvement - earlytimes.in
AngioDynamics Eyes Growth Despite Tariffs - Yahoo Finance
AngioDynamics (NASDAQ:ANGO) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
ANGIODYNAMICS INC SEC 10-Q Report - TradingView
AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance
AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha
Why Did AngioDynamics Stock Pop Today? - The Motley Fool
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga
AngioDynamics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q1 2026 Earnings Call, Oct 02, 2025 - MarketScreener
AngioDynamics, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 - MarketScreener
AngioDynamics Inc. Q1 Loss Decreases, Beats Estimates - Nasdaq
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In FocusSPDR S&P 500 (ARCA:SPY) - Benzinga
Voya Investment Management LLC Has $103,000 Position in AngioDynamics, Inc. $ANGO - Defense World
AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings - Benzinga
Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance
AngioDynamics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
What drives AngioDynamics Inc stock pricePrice Volatility Patterns & Master Technical Analysis With Free Tools - earlytimes.in
Chart based analysis of AngioDynamics Inc. trendsJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Why AngioDynamics Inc. (UG2) stock signals breakout potentialJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Is AngioDynamics Inc. (UG2) stock a safe buy pre earningsMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
How buyback programs support AngioDynamics Inc. (UG2) stock2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
What valuation ratios show for AngioDynamics Inc. (UG2) stock2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Assenagon Asset Management S.A. Purchases 72,826 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Angiodynamic Inc (ANGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.41%
0.47%
자본화:
|
볼륨(24시간):